Page last updated: 2024-08-24

rolofylline and Kidney Diseases

rolofylline has been researched along with Kidney Diseases in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	1 (25.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gottlieb, SS	1
Cleland, JG; Cotter, G; DeLucca, P; Dittrich, HC; Givertz, MM; Mansoor, GA; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Voors, AA; Weatherley, BD	1
Callahan, J; Dittrich, HC; Dowling, T; Gupta, DK; Hack, TC; Thomson, S	1
Heyne, N; Osswald, H; Yao, K	1

Reviews

1 review(s) available for rolofylline and Kidney Diseases

Article	Year
Adenosine A1 antagonists and the cardiorenal syndrome. Current heart failure reports, 2008, Volume: 5, Issue:2 Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines	2008

Article

Year

Adenosine A1 antagonists and the cardiorenal syndrome.

Current heart failure reports, 2008, Volume: 5, Issue:2

Topics: Adenosine A1 Receptor Antagonists; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Furosemide; Glomerular Filtration Rate; Heart Failure; Humans; Kidney Diseases; Kidney Function Tests; Male; Mice; Prognosis; Randomized Controlled Trials as Topic; Receptor, Adenosine A1; Risk Assessment; Severity of Illness Index; Syndrome; Treatment Outcome; Xanthines

2008

Trials

2 trial(s) available for rolofylline and Kidney Diseases

Article	Year
Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylli Journal of the American College of Cardiology, 2011, May-10, Volume: 57, Issue:19 Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Kidney; Kidney Diseases; Male; Pilot Projects; Stroke Volume; Treatment Outcome; Xanthines	2011
The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment. Journal of cardiac failure, 2007, Volume: 13, Issue:8 Topics: Adenosine A1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Ambulatory Care; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Receptor, Adenosine A1; Renal Plasma Flow; Xanthines	2007

Article

Year

Effects of the adenosine A1 receptor antagonist rolofylline on renal function in patients with acute heart failure and renal dysfunction: results from PROTECT (Placebo-Controlled Randomized Study of the Selective Adenosine A1 Receptor Antagonist Rolofylli

Journal of the American College of Cardiology, 2011, May-10, Volume: 57, Issue:19

Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Double-Blind Method; Female; Heart Failure; Hospitalization; Humans; Kidney; Kidney Diseases; Male; Pilot Projects; Stroke Volume; Treatment Outcome; Xanthines

2011

The effect of KW-3902, an adenosine A1 receptor antagonist, on renal function and renal plasma flow in ambulatory patients with heart failure and renal impairment.

Journal of cardiac failure, 2007, Volume: 13, Issue:8

Topics: Adenosine A1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Ambulatory Care; Cross-Over Studies; Double-Blind Method; Female; Heart Failure; Humans; Kidney; Kidney Diseases; Kidney Function Tests; Male; Middle Aged; Receptor, Adenosine A1; Renal Plasma Flow; Xanthines

2007

Other Studies

1 other study(ies) available for rolofylline and Kidney Diseases

Article	Year
Effect of the selective adenosine A1-receptor antagonist KW-3902 on tubuloglomerular feedback in radiocontrast-media-induced nephropathy in rats with chronic nitric oxide deficiency. Japanese journal of pharmacology, 2000, Volume: 84, Issue:3 Topics: Animals; Chronic Disease; Contrast Media; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Nitric Oxide; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines	2000

Article

Year

Effect of the selective adenosine A1-receptor antagonist KW-3902 on tubuloglomerular feedback in radiocontrast-media-induced nephropathy in rats with chronic nitric oxide deficiency.

Japanese journal of pharmacology, 2000, Volume: 84, Issue:3

Topics: Animals; Chronic Disease; Contrast Media; Kidney Diseases; Kidney Glomerulus; Kidney Tubules; Male; Nitric Oxide; Purinergic P1 Receptor Antagonists; Rats; Rats, Sprague-Dawley; Xanthines

2000